Archive for September, 2010

« Previous Entries

Antipsychotic switching prevalent in schizophrenia

Thursday, September 30th, 2010

Antipsychotic switching is common in the treatment of patients with schizophrenia and can be predicted by a small number of variables, researchers have found. Writing in the journal BMC Psychiatry, Haya Ascher-Svanum (Eli Lilly and Company, Indianapolis, Indiana, USA) and team explain that antipsychotic medications are the mainstay of schizophrenia treatment, but some patients may need […]

Seasonal flu vaccination reduces MI risk

Thursday, September 30th, 2010

Source: MedWire News Results from a UK study suggest that seasonal influenza vaccination reduces the risk for a first acute myocardial infarction (MI). Writing in the Canadian Medical Association Journal, A Niroshan Siriwardena (University of Lincoln) and team explain: “Significant increases in acute MI occur during peak winter incidence of pneumonia, influenza, and influenza-like syndrome, particularly […]

Blood glucose promotes lipoprotein(a) oxidization

Wednesday, September 29th, 2010

Source: MedWire News Blood glucose levels influence the oxidization of lipoprotein(a), a molecule with potent atherosclerotic properties, research has found. The study was undertaken by Kazuhiko Kotani (Jichi Medical University, Tochigi, Japan) and co-workers and aimed to investigate the association between circulating levels of oxidized Lp(a) [oxLp(a)] and cardiometabolic variables. The study participants were 70 […]

Exercise may reduce fractures in elderly women

Wednesday, September 29th, 2010

Source: MedWire News Home-based exercises that focus on balance and leg strength reduce important risk factors for falls and fractures among elderly women with osteopenia, Finnish researchers report. Raija Korpelainen (Oulu Deaconess Institute) and colleagues found that women aged 70-73 years who took part in a 30-month exercise program (n=84) preserved their walking speed, postural […]

FDA Restricts Use of Diabetes Drug Avandia

Friday, September 24th, 2010

Source: WebMD FDA Decides Not to Ban Avandia, but Puts Restrictions on How It’s Used The FDA will not ban Avandia — but stringent restrictions will make it far harder for doctors to prescribe the safety-troubled diabetes drug. The European Medicines Agency took harsher action. European sales of Avandia-containing drugs will be suspended over the next few months, although the […]

Statins reduce markers of inflammation

Thursday, September 23rd, 2010

Source: MedWire News Statin therapy is associated with significant reductions in inflammatory parameters such as white blood cell count (WBC) and C-reactive protein (CRP), an analysis of US population data indicates. The investigators say their results support the hypothesis that statins have anti-inflammatory properties, although they admit the potential mechanisms underlying such an effect are […]

Vitamin D levels inversely correlated with incident diabetes in US women

Tuesday, September 21st, 2010

Source: MedWire News Blood levels of vitamin D are inversely associated with the risk for developing Type 2 diabetes in women, independently of other risk factors, a case-control study suggests. The authors of the study call for randomized, controlled trials to test the hypothesis that vitamin D supplementation might reduce incident diabetes. Anastassios Pittas (Tufts […]

Cilostazol might be superior to aspirin for secondary stroke prevention

Monday, September 20th, 2010

Source: MedWire News Cilostazol is noninferior to aspirin for recurrent stroke prevention and is associated with less bleeding risk, say the CSPS 2 investigators. CSPS 2 (Cilostazol Stroke Prevention Study 2) enrolled patients who had suffered ischemic stroke within the preceding 26 weeks. The analysis, reported in The Lancet Neurology, includes 1337 patients who were randomly […]

Acne linked to suicidal ideation and depression in adolescents

Friday, September 17th, 2010

Source: MedWire News Adolescents with substantial acne have more frequent suicidal ideation and depression than those without the skin condition, say researchers who believe this is likely to be a result of the burden of acne rather than an adverse therapy-associated effect. Writing in the Journal of Investigative Dermatology, Jon Halvorsen (University of Oslo, Norway) and […]

PSA test at 60 years predicts risk for prostate cancer death by 85

Wednesday, September 15th, 2010

Source: MedWire News The prostate-specific antigen (PSA) levels of 60-year old men can predict the likelihood of death from the disease in the subsequent 25 years, report researchers. The team says that the association between PSA level and prostate cancer death is stronger than the association between PSA and cancer detectable at biopsy, suggesting that […]

« Previous Entries